Background: The augmentation of labor is a medical practice employed to enhance uterine contractions concerning their duration, frequency, and intensity. The primary aim is to reduce the duration of labor and minimize potential adverse outcomes for both the mother and the fetus that might result from prolonged labor. Oxytocin, a hormone and medication, is the most commonly used drug for this purpose. However, it's worth noting that there isn't a universally accepted standard dosage regimen for oxytocin. Methods: In this study, a total of 200 patients who were in active labor and exhibited inadequate uterine contractions were included. To ensure unbiased results, the patients were selected randomly, with every other case being assigned to receive either a high dose or a low dose of oxytocin for labor augmentation. Throughout the labor process, the patients were closely monitored, and the outcomes of the two groups were systematically compared. Results: In this study, it was observed that the majority of patients in both the high dose and low dose oxytocin groups delivered vaginally, with 78% in the high dose group and 90% in the low dose group. The mean duration of augmentation to delivery was quite similar between the two groups, with 7.20 hours for the high dose group and 7.45 hours for the low dose group. However, it's worth noting that a small percentage of patients (12%) in the high dose group experienced maternal complications, while none were encountered in the low dose group. Conclusion: In summary, the study's conclusion suggests that using a high dose regimen of oxytocin can lead to a reduction in the duration of labor. However, this advantage in terms of shorter labor was counterbalanced by a higher rate of cesarean sections and an increased incidence of maternal and fetal complications. On the other hand, while the low dose regimen did not result in a significant reduction in the duration of labor, it showed a lower rate of cesarean sections and fewer complications for both mothers and babies.